Exagen and the Lupus Foundation of America Partner on New Initiative to Reduce the Time to an Accurate Lupus Diagnosis


You May Also Like

Cyclacel Pharmaceuticals to Release Second Quarter 2016 Financial Results

BERKELEY HEIGHTS, N.J., Aug. 03, 2016 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) ...

AnaptysBio to Participate in Upcoming Investor Conferences

SAN DIEGO, Oct. 31, 2017 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq:ANAB), a clinical-stage biotechnology ...